EP1421085A2 - Verfahren for zur herstellung eines 14-hydroxynormorphinon-derivats - Google Patents

Verfahren for zur herstellung eines 14-hydroxynormorphinon-derivats

Info

Publication number
EP1421085A2
EP1421085A2 EP02767405A EP02767405A EP1421085A2 EP 1421085 A2 EP1421085 A2 EP 1421085A2 EP 02767405 A EP02767405 A EP 02767405A EP 02767405 A EP02767405 A EP 02767405A EP 1421085 A2 EP1421085 A2 EP 1421085A2
Authority
EP
European Patent Office
Prior art keywords
formula
derivative
benzyl
hydroxynormoφhinone
moφhine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP02767405A
Other languages
English (en)
French (fr)
Other versions
EP1421085B1 (de
Inventor
Joannes Theodorus Maria Linders
Pieter Vrijhof
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme BV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Priority to EP02767405A priority Critical patent/EP1421085B1/de
Publication of EP1421085A2 publication Critical patent/EP1421085A2/de
Application granted granted Critical
Publication of EP1421085B1 publication Critical patent/EP1421085B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone

Definitions

  • an oxidizing agent effective for oxidizing allylic hydroxy groups to form keto groups, where a morphinone compound of the formula III is prepared.
  • the oxidizing agent is sodium dichromate.
  • Ri is ethyl. For R 2 benzyl is most preferred.
  • the novel intermediates of formula II, III and IV form each another aspect of the present invention.
  • the intermediates of formula II, III and IV are in particular preferred wherein is ethyl.
  • Most preferred are the intermediates of formula II, III and IV wherein Ri is ethyl and R 2 is benzyl.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
EP02767405A 2001-08-23 2002-08-15 Verfahren for zur herstellung eines 14-hydroxynormorphinon-derivats Expired - Lifetime EP1421085B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP02767405A EP1421085B1 (de) 2001-08-23 2002-08-15 Verfahren for zur herstellung eines 14-hydroxynormorphinon-derivats

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP01203187 2001-08-23
EP01203187 2001-08-23
EP02767405A EP1421085B1 (de) 2001-08-23 2002-08-15 Verfahren for zur herstellung eines 14-hydroxynormorphinon-derivats
PCT/EP2002/009280 WO2003018588A2 (en) 2001-08-23 2002-08-15 Process for the preparation of a 14-hydroxynormorphinone derivative

Publications (2)

Publication Number Publication Date
EP1421085A2 true EP1421085A2 (de) 2004-05-26
EP1421085B1 EP1421085B1 (de) 2010-04-28

Family

ID=8180821

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02767405A Expired - Lifetime EP1421085B1 (de) 2001-08-23 2002-08-15 Verfahren for zur herstellung eines 14-hydroxynormorphinon-derivats

Country Status (25)

Country Link
US (1) US7435817B2 (de)
EP (1) EP1421085B1 (de)
JP (1) JP4559730B2 (de)
KR (1) KR100901402B1 (de)
CN (1) CN1271072C (de)
AR (1) AR035289A1 (de)
AT (1) ATE466016T1 (de)
AU (1) AU2002331163B2 (de)
BR (1) BRPI0211899B8 (de)
CA (1) CA2457671C (de)
DE (1) DE60236171D1 (de)
EC (1) ECSP044984A (de)
ES (1) ES2345327T3 (de)
HR (1) HRP20040161A2 (de)
HU (1) HUP0401600A3 (de)
IL (1) IL160193A0 (de)
IS (1) IS7153A (de)
MX (1) MXPA04001647A (de)
NO (1) NO328655B1 (de)
NZ (1) NZ531152A (de)
PE (1) PE20030460A1 (de)
PL (1) PL368732A1 (de)
RU (1) RU2297419C2 (de)
WO (1) WO2003018588A2 (de)
ZA (1) ZA200401016B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006126529A1 (ja) * 2005-05-25 2006-11-30 Shionogi & Co., Ltd. ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体
ES2357216T3 (es) * 2005-06-16 2011-04-20 Mallinckrodt, Inc. Una ruta de síntesis de 14-hidroxil-opiáceos a través de 1-halo-tebaína o análogos.
CA2681740A1 (en) * 2007-03-23 2008-10-02 Mallinckrodt Inc. Improved preparation of oxymorphone from oripavine
CN101033228B (zh) * 2007-04-04 2010-05-19 复旦大学 14-羟基-7,8-二氢降吗啡酮的制备方法
ES2423180T3 (es) 2007-04-16 2013-09-18 Mallinckrodt Llc Nueva reducción de opiáceos mediante reacción de transferencia de hidrógeno catalítica
NZ586187A (en) * 2007-12-17 2013-07-26 Mallinckrodt Llc Processes for the synthesis of sinomenine derivatives and their intermediate
CN101896487A (zh) 2007-12-17 2010-11-24 马林克罗特公司 N-甲基吗啡喃的n-脱甲基化
NZ586203A (en) * 2007-12-17 2012-10-26 Mallinckrodt Llc Process and compounds for the production of (+) opiates
CA2798885C (en) 2010-05-10 2014-11-18 Euro-Celtique S.A. Combination of active loaded granules with additional actives
BR112012028773A2 (pt) 2010-05-10 2016-07-19 Euro Celtique Sa composições farmacêuticas compreendendo hidromorfona e naloxona
AU2011252040C1 (en) 2010-05-10 2015-04-02 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
EP2580201B1 (de) 2010-06-11 2017-08-02 Rhodes Technologies Übergangsmetallkatalysierte verfahren zur herstellung von n-allyl-verbindungen und ihre verwendung
TWI471289B (zh) 2010-06-11 2015-02-01 Rhodes Technologies 使三級胺進行ｎ－脫烷反應之方法
BR112014005421A2 (pt) 2011-09-08 2017-04-04 Mallinckrodt Llc produção de alcaloides sem o isolamento de intermediários
WO2015015146A1 (en) * 2013-08-02 2015-02-05 Johnson Matthey Public Limited Company Process for the preparation of oxymorphone
EP3068397A1 (de) 2013-11-13 2016-09-21 Euro-Celtique S.A. Hydromorphon und naloxon zur behandlung von schmerzen und opioid-reizdarm-dysfunktionssyndrom
CN114621238B (zh) * 2020-12-10 2026-02-03 鲁南制药集团股份有限公司 一种制备纳呋拉啡的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199871B (it) 1984-03-27 1989-01-05 Mallinckrodt Inc Procedimento per la preparazione di norossimorfone dalla morfina e composti intermedi per tale procedimento
US5112975A (en) * 1984-03-27 1992-05-12 Mallinckrodt Specialty Chemicals Company Preparation of noroxymorphone from morphine
US4668685A (en) * 1984-07-05 1987-05-26 E.I. Du Pont De Nemours And Company Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
US5869669A (en) * 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
WO2000066588A1 (en) * 1999-05-05 2000-11-09 The Government Of The United States Of America, Represented By The Secretary, Departmentof Health A Nd Human Services Direct c-14 oxidation of opioids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO03018588A2 *

Also Published As

Publication number Publication date
AR035289A1 (es) 2004-05-05
ES2345327T3 (es) 2010-09-21
HUP0401600A3 (en) 2008-05-28
RU2004108210A (ru) 2005-04-10
AU2002331163B2 (en) 2008-02-21
IL160193A0 (en) 2004-07-25
KR20040027950A (ko) 2004-04-01
MXPA04001647A (es) 2004-05-31
PE20030460A1 (es) 2003-05-15
CN1271072C (zh) 2006-08-23
US20050038250A1 (en) 2005-02-17
WO2003018588B1 (en) 2004-02-26
BR0211899A (pt) 2004-09-21
ZA200401016B (en) 2004-10-19
RU2297419C2 (ru) 2007-04-20
ATE466016T1 (de) 2010-05-15
KR100901402B1 (ko) 2009-06-05
HUP0401600A2 (hu) 2004-11-29
NZ531152A (en) 2005-11-25
DE60236171D1 (de) 2010-06-10
HK1063803A1 (en) 2005-01-14
US7435817B2 (en) 2008-10-14
NO328655B1 (no) 2010-04-19
HRP20040161A2 (en) 2004-06-30
IS7153A (is) 2004-02-13
WO2003018588A3 (en) 2003-11-27
JP2005502670A (ja) 2005-01-27
NO20040724L (no) 2004-02-19
BR0211899B1 (pt) 2014-01-21
CA2457671C (en) 2011-02-15
BRPI0211899B8 (pt) 2021-05-25
JP4559730B2 (ja) 2010-10-13
PL368732A1 (en) 2005-04-04
ECSP044984A (es) 2004-04-28
CA2457671A1 (en) 2003-03-06
EP1421085B1 (de) 2010-04-28
WO2003018588A2 (en) 2003-03-06
CN1545517A (zh) 2004-11-10

Similar Documents

Publication Publication Date Title
EP1421085B1 (de) Verfahren for zur herstellung eines 14-hydroxynormorphinon-derivats
AU2002331163A1 (en) Process for the Preparation of a 14-hydroxynormorphinone Compound
EP2112153B1 (de) Verfahren zur Verminderung von Alpha, Beta-ungesättigten Ketonen in Opioidzusammensetzungen
US5922876A (en) Preparation of oxymorphone from morphine
EP1893616B1 (de) Synthetische route zu 14-hydroxylopiaten über 1-halogenthebain oder analoga
JP2001518444A5 (de)
EP1664061B1 (de) Verfahren zur synthese von morphinanverbindungen und zwischenprodukten davon
Barber et al. Conversion of thebaine to codeine
US8106201B2 (en) Process for the synthesis of morphinane compounds and intermediates thereof
US20230357257A1 (en) Novel process for the synthesis of noroxymorphone from morphine
HK1063803B (en) Process for the preparation of a 14-hydroxynormorphinone derivative
US6790959B1 (en) Process for manufacturing thebaine
RU2236412C2 (ru) Способ получения производных морфинона, способ получения производных 14-гидроксиморфинона, и способ получения производных оксиморфона
TWI292761B (en) C-14 oxidation of morphine derivatives
HK1135107B (en) Method of reducing alpha, beta- unsaturated ketones in opioid compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

17P Request for examination filed

Effective date: 20040527

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1063803

Country of ref document: HK

17Q First examination report despatched

Effective date: 20050309

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: N.V. ORGANON

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 60236171

Country of ref document: DE

Date of ref document: 20100610

Kind code of ref document: P

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: ISLER & PEDRAZZINI AG

REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1063803

Country of ref document: HK

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2345327

Country of ref document: ES

Kind code of ref document: T3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100428

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100428

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100729

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100428

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100428

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100428

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100830

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100428

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100428

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100831

26N No opposition filed

Effective date: 20110131

REG Reference to a national code

Ref country code: NL

Ref legal event code: SD

Effective date: 20120116

REG Reference to a national code

Ref country code: CH

Ref legal event code: PFUS

Owner name: MSD OSS B.V., NL

Free format text: FORMER OWNER: N.V. ORGANON, NL

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20120308 AND 20120314

REG Reference to a national code

Ref country code: ES

Ref legal event code: PC2A

Owner name: MSD OSS B.V.

Effective date: 20120423

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 60236171

Country of ref document: DE

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 60236171

Country of ref document: DE

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE

Effective date: 20120619

Ref country code: DE

Ref legal event code: R081

Ref document number: 60236171

Country of ref document: DE

Owner name: MERCK, SHARP & DOHME B.V., NL

Free format text: FORMER OWNER: N.V. ORGANON, 5349 OSS, NL

Effective date: 20120619

Ref country code: DE

Ref legal event code: R081

Ref document number: 60236171

Country of ref document: DE

Owner name: MERCK SHARP & DOHME B.V., NL

Free format text: FORMER OWNER: N.V. ORGANON, 5349 OSS, NL

Effective date: 20120619

Ref country code: DE

Ref legal event code: R082

Ref document number: 60236171

Country of ref document: DE

Representative=s name: WUESTHOFF & WUESTHOFF, PATENTANWAELTE PARTG MB, DE

Effective date: 20120619

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100815

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100428

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100428

BECH Be: change of holder

Owner name: MERCK SHARP & DOHME B.V.

Effective date: 20130528

REG Reference to a national code

Ref country code: CH

Ref legal event code: PFUS

Owner name: MERCK SHARP AND DOHME B.V., NL

Free format text: FORMER OWNER: ORGANON BIO SCIENCES NEDERLAND B.V., NL

Ref country code: CH

Ref legal event code: PFUS

Owner name: ORGANON BIO SCIENCES NEDERLAND B.V., NL

Free format text: FORMER OWNER: MSD OSS B.V., NL

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 60236171

Country of ref document: DE

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: SD

Effective date: 20130814

REG Reference to a national code

Ref country code: FR

Ref legal event code: TP

Owner name: MERCK SHARP & DOHME B.V., NL

Effective date: 20130724

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 60236171

Country of ref document: DE

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE

Effective date: 20130705

Ref country code: DE

Ref legal event code: R081

Ref document number: 60236171

Country of ref document: DE

Owner name: MERCK SHARP & DOHME B.V., NL

Free format text: FORMER OWNER: MSD OSS B.V., 5349 OSS, NL

Effective date: 20130705

Ref country code: DE

Ref legal event code: R082

Ref document number: 60236171

Country of ref document: DE

Representative=s name: WUESTHOFF & WUESTHOFF, PATENTANWAELTE PARTG MB, DE

Effective date: 20130705

REG Reference to a national code

Ref country code: ES

Ref legal event code: PC2A

Owner name: MERCK SHARP & DOHME B.V.

Effective date: 20130903

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100728

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20131003 AND 20131009

REG Reference to a national code

Ref country code: AT

Ref legal event code: PC

Ref document number: 466016

Country of ref document: AT

Kind code of ref document: T

Owner name: MSD OSS B.V., NL

Effective date: 20131010

REG Reference to a national code

Ref country code: AT

Ref legal event code: PC

Ref document number: 466016

Country of ref document: AT

Kind code of ref document: T

Owner name: MERCK SHARP & DOHME B.V., NL

Effective date: 20140611

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 15

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 16

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20210715

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20210728

Year of fee payment: 20

Ref country code: AT

Payment date: 20210726

Year of fee payment: 20

Ref country code: IT

Payment date: 20210818

Year of fee payment: 20

Ref country code: IE

Payment date: 20210726

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20210908

Year of fee payment: 20

Ref country code: GB

Payment date: 20210728

Year of fee payment: 20

Ref country code: BE

Payment date: 20210715

Year of fee payment: 20

Ref country code: CH

Payment date: 20210713

Year of fee payment: 20

Ref country code: DE

Payment date: 20210713

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 60236171

Country of ref document: DE

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: NL

Ref legal event code: MK

Effective date: 20220814

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20220826

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20220814

REG Reference to a national code

Ref country code: BE

Ref legal event code: MK

Effective date: 20220815

REG Reference to a national code

Ref country code: IE

Ref legal event code: MK9A

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK07

Ref document number: 466016

Country of ref document: AT

Kind code of ref document: T

Effective date: 20220815

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20220815

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20220814

Ref country code: ES

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20220816